Ledger.Open graph →
SEC Form D · Amendment · filed July 26, 2018

Lung Therapeutics, Inc

Offering
$3.9M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Alexandra Hess · London, United KingdomDirectorHamish Cameron · London, United KingdomDirectorRichard B. Cook · Stevensville, MDExec · DirectorKathryn Stewart · LARKSPUR, CADirectorCatherine Bingham · London, United KingdomDirectorMichael Ross · London, United KingdomDirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorMichael Dineen · Campbell, CAExec · DirectorBarrett Brown · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗